Strata Critical Medical Statistics
Total Valuation
SRTA has a market cap or net worth of $371.38 million. The enterprise value is $298.93 million.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTA has 86.37 million shares outstanding. The number of shares has increased by 5.22% in one year.
| Current Share Class | 86.37M |
| Shares Outstanding | 86.37M |
| Shares Change (YoY) | +5.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.55% |
| Owned by Institutions (%) | 55.00% |
| Float | 62.61M |
Valuation Ratios
The trailing PE ratio is 9.20.
| PE Ratio | 9.20 |
| Forward PE | n/a |
| PS Ratio | 1.29 |
| Forward PS | 1.50 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 2.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 7.40 |
| EV / Sales | 1.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.39 |
| Quick Ratio | 4.07 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.88% and return on invested capital (ROIC) is -5.82%.
| Return on Equity (ROE) | -12.88% |
| Return on Assets (ROA) | -5.12% |
| Return on Invested Capital (ROIC) | -5.82% |
| Return on Capital Employed (ROCE) | -8.23% |
| Revenue Per Employee | $866,510 |
| Profits Per Employee | $130,281 |
| Employee Count | 310 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -255,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.24% in the last 52 weeks. The beta is 1.98, so SRTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | +15.24% |
| 50-Day Moving Average | 4.96 |
| 200-Day Moving Average | 3.95 |
| Relative Strength Index (RSI) | 41.37 |
| Average Volume (20 Days) | 991,698 |
Short Selling Information
The latest short interest is 2.60 million, so 3.01% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.39M |
| Short % of Shares Out | 3.01% |
| Short % of Float | 4.15% |
| Short Ratio (days to cover) | 2.32 |
Income Statement
In the last 12 months, SRTA had revenue of $268.62 million and earned $40.39 million in profits. Earnings per share was $0.50.
| Revenue | 268.62M |
| Gross Profit | 63.80M |
| Operating Income | -25.30M |
| Pretax Income | -33.51M |
| Net Income | 40.39M |
| EBITDA | -17.63M |
| EBIT | -25.30M |
| Earnings Per Share (EPS) | $0.50 |
Full Income StatementBalance Sheet
The company has $75.92 million in cash and $3.47 million in debt, giving a net cash position of $72.45 million or $0.84 per share.
| Cash & Cash Equivalents | 75.92M |
| Total Debt | 3.47M |
| Net Cash | 72.45M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 283.00M |
| Book Value Per Share | 3.29 |
| Working Capital | 94.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$42.36 million and capital expenditures -$12.34 million, giving a free cash flow of -$54.70 million.
| Operating Cash Flow | -42.36M |
| Capital Expenditures | -12.34M |
| Free Cash Flow | -54.70M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
Gross margin is 23.75%, with operating and profit margins of -9.42% and 15.04%.
| Gross Margin | 23.75% |
| Operating Margin | -9.42% |
| Pretax Margin | -12.47% |
| Profit Margin | 15.04% |
| EBITDA Margin | -6.56% |
| EBIT Margin | -9.42% |
| FCF Margin | n/a |
Dividends & Yields
SRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.22% |
| Shareholder Yield | -5.22% |
| Earnings Yield | 10.87% |
| FCF Yield | -14.73% |
Analyst Forecast
The average price target for SRTA is $7.25, which is 68.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.25 |
| Price Target Difference | 68.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTA has an Altman Z-Score of 3.8 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.8 |
| Piotroski F-Score | 3 |
